This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies.Continue
Every patient prescribed Lixiana will receive a Patient Alert Card in the medication pack.
This will inform doctors, dentists, pharmacists and other healthcare professionals about the patient’s anticoagulation treatment, along with emergency contact details. Encourage patients to have this card with them at all times and to show it to healthcare professionals prior to any consultation or procedure.
Patients should be reminded of the importance of compliance to their treatment regimen, the need to watch for signs and symptoms of bleeding and when to seek medical advice.
Patient Alert Cards are available from
MedInfo@daiichi-sankyo.co.uk
or by calling 08000285122.
If you would like to make a comment or send us feedback on this material, click here.
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine.
This PIL is in PDF format and so you must have a PDF reader installed on your device to read it.
Text only version for the visually impaired
Below is a text only representation of the Patient Information leaflet. The original may contain images or tables and can be viewed in PDF format using the link above. This PIL may be available from the RNIB in large print, Braille or audio CD. For further information please call the RNIB Medicine Leaflet line on 0800 198 5000. The product code(s) for this leaflet is/are: EU/1/15/993/016, EU/1/15/993/001, EU/1/15/993/002, EU/1/15/993/005, EU/1/15/993/006, EU/1/15/993/007, EU/1/15/993/008, EU/1/15/993/009, EU/1/15/993/010, EU/1/15/993/011, EU/1/15/993/012, EU/1/15/993/013, EU/1/15/993/014, EU/1/15/993/015.
Lixiana 15mg, 30mg, 60mg film-coated tablets
Package leaflet: Information for the user
Lixiana 15 mg film-coated tablets
Lixiana 30 mg film-coated tablets
Lixiana 60 mg film-coated tablets
Edoxaban
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet
1. What Lixiana is and what it is used for
2. What you need to know before you take Lixiana
3. How to take Lixiana
4. Possible side effects
5. How to store Lixiana
6. Contents of the pack and other information
1. What Lixiana is and what it is used for
Lixiana contains the active substance edoxaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming. It works by blocking the activity of factor Xa, which is an important component of blood clotting.
Lixiana is used in adults to:
2. What you need to know before you take Lixiana
Do not take Lixiana:
Warnings and precautions
Talk to your doctor or pharmacist before taking Lixiana,
Lixiana 15 mg is only to be used when changing from Lixiana 30 mg to a vitamin K antagonist (e.g. warfarin) (see section 3. How to take Lixiana).
If you need to have an operation:
It is very important to take Lixiana before and after the operation exactly at the times you have been told by your doctor. If possible, Lixiana should be stopped at least 24 hours before an operation. Your doctor will determine when to restart Lixiana.
Children and adolescents
Lixiana is not recommended in children and adolescents under 18 years of age. There is no information on its use in children and adolescents.
Other medicines and Lixiana
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are taking any of the following:
Tell your doctor before taking Lixiana, because these medicines may increase the effects of Lixiana and the chance of unwanted bleeding. Your doctor will decide, if you should be treated with Lixiana and if you should be kept under observation.
If you are taking any of the following:
If any of the above apply to you, tell your doctor before taking Lixiana, because the effect of Lixiana may be reduced. Your doctor will decide if you should be treated with Lixiana and if you should be kept under observation.
Pregnancy and breast-feeding
Do not take Lixiana if you are pregnant or breast-feeding. If there is a chance that you could become pregnant, use a reliable contraceptive while you are taking Lixiana. If you become pregnant while you are taking Lixiana, immediately tell your doctor, who will decide how you should be treated.
Driving and using machines
Lixiana has no or negligible effects on your ability to drive or use machines.
3. How to take Lixiana
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
How much to take
The recommended dose is one 60 mg tablet once daily.
How to take the tablet
Swallow the tablet, preferably with water.
Lixiana can be taken with or without food.
Your doctor may change your anticoagulant treatment as follows:
Changing from vitamin K antagonists (e.g. warfarin) to Lixiana
Stop taking the vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to start taking Lixiana.
Changing from non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban) to Lixiana
Stop taking the previous medicines (e.g. dabigatran, rivaroxaban, or apixaban) and start Lixiana at the time of the next scheduled dose.
Changing from parenteral anticoagulants (e.g. heparin) to Lixiana
Stop taking the anticoagulant (e.g. heparin) and start Lixiana at the time of the next scheduled anticoagulant dose.
Changing from Lixiana to vitamin K antagonists (e.g. warfarin)
If you currently take 60 mg Lixiana:
Your doctor will tell you to reduce your dose of Lixiana to a 30 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Lixiana.
If you currently take 30 mg (dose reduced) Lixiana:
Your doctor will tell you to reduce your dose of Lixiana to a 15 mg tablet once daily and to take it together with a vitamin K antagonist (e.g. warfarin). Your doctor will need to do blood measurements and will instruct you when to stop taking Lixiana.
Changing from Lixiana to non-VKA oral anticoagulants (dabigatran, rivaroxaban, or apixaban)
Stop taking Lixiana and start the non-VKA anticoagulant (e.g. dabigatran, rivaroxaban, or apixaban) at the time of the next scheduled dose of Lixiana.
Changing from Lixiana to parenteral anticoagulants (e.g. heparin)
Stop taking Lixiana and start the parenteral anticoagulant (e.g. heparin) at the time of the next scheduled dose of Lixiana.
If you take more Lixiana than you should
Tell your doctor immediately if you have taken too many Lixiana tablets.
If you take more Lixiana than recommended, you may have an increased risk of bleeding.
If you forget to take Lixiana
You should take the tablet immediately and then continue the following day with the once daily tablet as usual. Do not take a double dose on the same day to make up for a forgotten dose.
If you stop taking Lixiana
Do not stop taking Lixiana without talking to your doctor first, because Lixiana treats and prevents serious conditions.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Like other similar medicines (medicines to reduce blood clotting), Lixiana may cause bleeding which may potentially be life-threatening. In some cases the bleeding may not be obvious.
If you experience any bleeding event that does not stop by itself or if you experience signs of excessive bleeding (exceptional weakness, tiredness, paleness, dizziness, headache or unexplained swelling) consult your doctor immediately.
Your doctor may decide to keep you under closer observation or change your medicine.
Overall list of possible side effects:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
Ireland
United Kingdom
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Lixiana
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on each blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Lixiana contains
What Lixiana looks like and contents of the pack
Lixiana 15 mg film-coated tablets are orange, round-shaped (6.7 mm diameter) and debossed with “DSC L15” on one side.
They come in blisters in cartons of 10 film-coated tablets or unit dose blisters in cartons of 10 x 1 film-coated tablets.
Lixiana 30 mg film-coated tablets are pink, round-shaped (8.5 mm diameter) and debossed with “DSC L30” on one side.
They come in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or unit dose blisters in cartons of 10 x 1, 50 x 1, or 100 x 1 film-coated tablets.
Lixiana 60 mg film-coated tablets are yellow, round-shaped (10.5 mm diameter) and debossed with “DSC L60” on one side.
They come in blisters in cartons of 10, 14, 28, 30, 56, 60, 84, 90, 98 or 100 film-coated tablets or unit dose blisters in cartons of 10 x 1, 50 x 1, or 100 x 1 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in 04/2016
Other sources of information
Detailed information on this product is available by scanning the QR Code below with a smartphone. The same information is also available on the following URL: www.dspatient.eu.
Detailed information on this medicine is available on the European Medicines Agency web site: http://www.ema.europa.eu.